NASDAQ:NTLA
Intellia Therapeutics
- Stock
Last Close
23.00
30/08 20:00
Market Cap
2.23B
Beta: 1.85
Volume Today
1.37M
Avg: 1.10M
PE Ratio
−4.82
PFCF: −5.44
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 6.04M - | 16.48M 172.65% | 26.12M 58.49% | 30.43M 16.53% | 43.10M 41.63% | 57.99M 34.55% | 33.05M 43.01% | 52.12M 57.69% | 36.27M 30.40% | ||
cost of revenue | 1.66M - | 108.41M - | 150.41M 38.74% | 6.89M 95.42% | 7.57M 9.88% | 8.98M 18.54% | |||||
gross profit | -1.66M - | 6.04M 464.65% | 16.48M 172.65% | 26.12M 58.49% | 30.43M 16.53% | -65.31M 314.60% | -92.41M 41.50% | 26.16M 128.31% | 44.55M 70.28% | 27.30M 38.72% | |
selling and marketing expenses | |||||||||||
general and administrative expenses | 3.57M - | 8.28M 132.11% | 16.80M 102.80% | 28.02M 66.84% | 32.19M 14.86% | 41.06M 27.55% | 44.17M 7.58% | 71.10M 60.96% | 90.31M 27.02% | 116.50M 29.00% | |
selling general and administrative expenses | 3.57M - | 8.28M 132.11% | 16.80M 102.80% | 28.02M 66.84% | 32.19M 14.86% | 41.06M 27.55% | 44.17M 7.58% | 71.10M 60.96% | 90.31M 27.02% | 116.50M 29.00% | |
research and development expenses | 10.74M - | 11.17M 4.00% | 31.84M 185.05% | 67.65M 112.46% | 89.11M 31.74% | 108.41M 21.66% | 150.41M 38.74% | 229.81M 52.79% | 419.98M 82.75% | 435.07M 3.59% | |
other expenses | |||||||||||
cost and expenses | 14.31M - | 19.45M 35.95% | 48.64M 150.03% | 95.67M 96.70% | 121.30M 26.79% | 149.47M 23.22% | 194.58M 30.18% | 300.90M 54.64% | 510.29M 69.58% | 551.57M 8.09% | |
operating expenses | 12.65M - | 19.45M 53.77% | 48.64M 150.03% | 95.67M 96.70% | 121.30M 26.79% | 149.47M 23.22% | 194.58M 30.18% | 300.90M 54.64% | 510.29M 69.58% | 551.57M 8.09% | |
interest expense | 8.54M - | ||||||||||
ebitda | -5.22M - | -13.08M 150.52% | -32.16M 145.85% | -69.56M 116.28% | -90.87M 30.64% | -100.78M 10.91% | -136.58M 35.52% | -267.85M 96.11% | -444.68M 66.02% | -506.21M 13.84% | |
operating income | -5.23M - | -13.41M 156.58% | -32.16M 139.83% | -69.56M 116.28% | -90.87M 30.64% | -106.37M 17.06% | -136.58M 28.41% | -267.85M 96.11% | -458.16M 71.05% | -515.29M 12.47% | |
depreciation and amortization | 4.50K - | 328K 7,188.89% | 1.10M 236.59% | 2.99M 171.20% | 4.46M 49.10% | 5.59M 25.16% | 6.31M 12.96% | 6.89M 9.19% | 13.48M 95.69% | 8.98M 33.44% | |
total other income expenses net | -9.08M - | 525K - | 2.01M 283.24% | 5.53M 174.70% | 6.83M 23.67% | 2.35M 65.59% | -42K 101.79% | -16.02M 38,047.62% | -15.73M 1.80% | ||
income before tax | -14.31M - | -13.41M 6.29% | -31.63M 135.92% | -67.54M 113.51% | -85.34M 26.35% | -99.53M 16.63% | -134.23M 34.86% | -267.89M 99.58% | -474.19M 77.01% | -481.19M 1.48% | |
income tax expense | -1.01M - | -1.10M 9.09% | -2.99M 171.20% | 5.53M 284.60% | -6.83M 223.67% | -8.66M 26.74% | -8.17M 5.64% | 16.02M 296.01% | -49.73M 410.40% | ||
net income | -14.31M - | -12.40M 13.36% | -31.63M 155.17% | -67.54M 113.51% | -85.34M 26.35% | -92.70M 8.62% | -125.57M 35.46% | -259.72M 106.83% | -490.21M 88.75% | -481.19M 1.84% | |
weighted average shs out | 485.88K - | 17.66M 3,535.45% | 22.22M 25.80% | 36.01M 62.03% | 43.07M 19.62% | 47.25M 9.70% | 55.99M 18.50% | 70.89M 26.63% | 76.97M 8.57% | 88.77M 15.33% | |
weighted average shs out dil | 485.88K - | 17.66M 3,535.45% | 22.22M 25.80% | 36.01M 62.03% | 43.07M 19.62% | 47.25M 9.70% | 55.99M 18.50% | 70.89M 26.63% | 76.97M 8.57% | 88.77M 15.33% | |
eps | -29.45 - | -0.70 97.62% | -1.42 102.86% | -1.88 32.39% | -1.98 5.32% | -1.96 1.01% | -2.24 14.29% | -3.66 63.39% | -6.37 74.04% | -5.42 14.91% | |
epsdiluted | -29.45 - | -0.70 97.62% | -1.42 102.86% | -1.88 32.39% | -1.98 5.32% | -1.96 1.01% | -2.24 14.29% | -3.66 63.39% | -6.37 74.04% | -5.42 14.91% |
All numbers in USD (except ratios and percentages)